Cooperative interaction of factor B and other complement components with mononuclear cells in the antibody-independent lysis of xenogeneic erythrocytes.
Open Access
- 1 September 1982
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 156 (3), 834-843
- https://doi.org/10.1084/jem.156.3.834
Abstract
Synergistic cytotoxicity is a term used to describe a cytotoxic system in which xenogeneic erythrocyte target cells are lysed in the presence of nonimmune human mononuclear effector cells and antibody-depleted normal human serum. Neither the mononuclear cells nor the serum alone are cytolytic to the target erythrocytes. Previous studies showed that the serum activity is not Ig and is heat-labile, suggesting a similarity to serum complement (C). Sera deficient in various C components and highly purified single C components were tested with whole mononuclear cell populations and purified monocytes and lymphocytes to further characterize this cytotoxicity system. Whole mononuclear cell populations failed to mediate target cell lysis in sera deficient in C5 or factor B. C3-deficient serum, even in the presence of anti-C3 antibody, supported synergistic cytotoxicity normally. Purified lymphocytes were also normally cytotoxic in C3-deficient serum but failed to lyse targets in sera deficient in C5, C7, C8 or depleted of factor B. Purified monocytes failed to lyse the target cells only in factor B-depleted serum and could lyse the target cells in serum-free medium when purified factor B alone was added. Monocyte-mediated cytotoxicity induced by factor B was inhibited 73-100% by adding lymphocytes back to the purified monocytes. Thus, both lymphocytes and monocytes can serve as effector cells in this form of cytotoxicity but require cooperative interaction with different sets of C components. In addition, lymphocytes can modulate the monocyte-mediated form of target cell lysis associated with factor B.This publication has 17 references indexed in Scilit:
- Biosynthesis of complement by human monocytesClinical Immunology and Immunopathology, 1981
- Fifth component of human complement: purification from plasma and polypeptide chain structureBiochemistry, 1979
- The induction of macrophage spreading by factor B of the properdin system.The Journal of Experimental Medicine, 1979
- Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.JCI Insight, 1976
- Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activationImmunochemistry, 1976
- Complete absence of the third component of complement in man.JCI Insight, 1975
- Biosynthetic Defect in Monocytes from Human Beings with Genetic Deficiency of the Second Component of ComplementNew England Journal of Medicine, 1975
- [91] Immunoaffinity chromatography of proteinsMethods in Enzymology, 1974
- HOMOZYGOUS DEFICIENCY OF C3 IN A PATIENT WITH REPEATED INFECTIONSThe Lancet, 1972
- IN VIVO STUDIES IN C4-DEFICIENT GUINEA PIGSThe Journal of Experimental Medicine, 1971